Determinants of global clinical change assessment in patients with early Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 3, 1998, Pages 157-163

  Claus, Jules J ^a   Teunisse, Saskia ^a   Walstra, Gerard J M ^a   Van Gool, Willem A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Alzheimer's disease; Clinical trials; Global clinical impression

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; CAREGIVER; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC VALUE; DISEASE COURSE; DISSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; BEHAVIOR; CAREGIVERS; COGNITION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; TIME FACTORS;

EID: 0031917639     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017041     Document Type: Article

References (25)

1. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI, for the Tacrine Study Group: A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994;271:985-991.
2. Davis KL, Thai LJ, Gamzu ER, et al: A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 1992;327:1253-1259.
3. Beneke M, Rasmus W: 'Clinical Global Impressions' (ECDEU): Some critical comments. Pharmacopsychiatry 1992;25:171-176.
4. Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J, for the Tacrine Study Group: A controlled trial of tacrine in Alzheimer's disease. JAMA 1992;268:2523-2529.
5. Chatellier G, Laclomblez L, on behalf of Groupe Français d'Etude de la Tétrahydroaminoacridine: Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: A multicentre trial. BMJ 1990;300:495-499.
6. Dahlke F, Lohaus A, Gutzmann H: Reliability and clinical concepts underlying global judgments in dementia: Implications for clinical research. Psychopharmacol Bull 1992;28:425-432.
7. Lehmann E: Practical and valid approach to evaluate the efficacy of nootropic drugs by means of rating scales. Pharmacopsychiatry 1984;17:71-75.
8. Knopman DS, Knapp MJ, Gracon SI, Davis CS: The clinical interview-based impression (CIBI): A clinician's global change rating scale in Alzheimer's disease. Neurology 1994;44:2315-2321.
9. Boothby H: Measuring change in dementia: The reliability of clinical global assessments; in Levy R, Howard R (eds): Developments in Dementia and Functional Disorders in the Elderly. Petersfield, Wrightson, 1995. pp 97-102.
10. Schneider LS, Olin JT: Clinical global impressions in Alzheimer's clinical trials. Int Psychogeriatr 1996;8:277-288.
11. Mohr E, Feldman H, Gauthier S: Canadian guidelines for the development of antidementia therapies: A conceptual summary. Can J Neurol Sci 1995;22:62-71.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984;34:939-944.
13. Teunisse S, Bollen AE, van Gool WA, Walstra GJM: Dementia and subnormal levels of vitamin B12: effects of replacement therapy on severity of dementia. J Neurol 1996;243:522-529.
14. Derix MM, Hofstede AB, Teunisse S, Hijdra A, Walstra GJ, Weinstein HC, van Gool WA: CAMDEX-N: The Dutch version of the Cambridge Examination for Mental Disorders of the Elderly with automatic data processing. Tijdschr Gerontol Geriatr 1991;22:143-150.
15. Roth M, Huppert FA, Tym E, Mountjoy CQ: CAMDEX, the Cambridge Examination for Mental Disorders of the Elderly. Cambridge, Cambridge University Press, 1988.
16. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Lindeboom J, ter Horst R, Hooyer C, Drinkgreve M, Jonker C: Some psychometric properties of the CAMCOG. Psychol Med 1993;23:213-219.
18. Teunisse S, Derix MMA, van Crevel H: Assessing the severity of dementia: Patient and caregiver. Arch Neurol 1991;48:274-277.
19. Teunisse S: Activities of daily living scales in dementia: Their development and future; in Levy R, Howard R (eds): Developments in Dementia and Functional Disorders in the Elderly. Petersfield, Wrightson, 1995, pp 85-95.
20. Teri L, Truax P, Logsdon R, Uomoto J, Zarit S, Vitaliano PP: Assessment of behavioral problems in dementia: the Revised Memory and Behavior Problems Checklist. Psychol Aging 1992;7:622-631.
21. Vernooij-Dassen M: Dementie en thuiszorg: een onderzoek naar determinanten van het competentiegevoel van centrale verzorgers en het effect van professionele interventie. Amsterdam: Swets & Zeitlinger, 1993.
22. Verhage F: Intelligentie en leeftijd. Assen, van Gorcum, 1964.
23. Netherlands Central Bureau of Statistics: Standard classification of education SOI-1978. Voorburg, Netherlands Central Bureau of Statistics, 1987.
24. International Standard Classification of Education. Paris, Unesco, 1976.
25. BMDP Statistical Software Manual. Berkeley, University of California Press, 1992.